For research use only. Not for therapeutic Use.
Garadacimab（Cat No.:I042094）is a monoclonal antibody designed to inhibit Factor XIa, a key protein involved in the coagulation cascade. By targeting Factor XIa, garadacimab aims to reduce excessive blood clotting and inflammation associated with conditions like hereditary angioedema (HAE) and potentially other clotting disorders. Its mechanism of action helps to prevent abnormal activation of the clotting system, which can lead to unwanted blood clots. Garadacimab is being evaluated in clinical trials for its safety, effectiveness, and potential to manage bleeding and clotting disorders, particularly in rare diseases like HAE.
| Catalog Number | I042094 |
| CAS Number | 2162134-62-3 |
| Purity | ≥95% |
